MEDITERRANEAN SCHOOL OF ONCOLOGY
www.mso.cinbo.org DIRECTOR Clara Natoli SCIENTIFIC SECRETARIAT
Consiglia Carella Michele De Tursi Antonino Grassadonia
Nicola Tinari
SCIENTIFIC ADVISORY BOARD Vincenzo Adamo
Barbara Barboni Roberto Bianco Giovanni Brandi Marco Carini Leonardo Della Salda
Corrado Ficorella Francesco Grignani
Lorenzo Lo Muzio Patrizia Querzoli
Antonio Russo Marina Scarpelli
Silverio Tomao Giuseppe Tonini ORGANIZING SECRETARIAT
Giovanna Di Credico OFFICES
Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio - Via dei Vestini, 31
66100 Chieti - Italy Phone: +39 0871 3556732
Fax +39 0871 3556707 [email protected] PROVIDER ECM ID. 50
Strategie S.r.L. - Via Piave 110/7 - Pescara Phone: +39 085 378220
[email protected] www.strategieonweb.it
CONFERENCE
OPEN ISSUES IN ONCOLOGY:
NEW DRUGS FOR GASTROINTESTINAL, OVARIAN AND
LUNG CANCER
20-21 May, 2016
Rome, Italy
Domus Sessoriana
P.zza Santa Croce in Gerusalemme n. 10
Director
Antonio Russo
Co - supported by:mso.cinbo.or g
CINBO
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
Evento n. ECM 50 - 150849155794 per Biologi e per
Medici Chirurghi Specialisti in: Genetica Medica, Oncologia, Radioterapia, Chirurgia Generale, Anatomia Patologica, Radiodiagnostica,
Ginecologia ed Ostetricia;
Crediti ECM: 10
Friday – May 20, 2016
Morning (11:00-13:00)
10.00 Participant registration 10.30 PRESENTATION OF THE MEETING
Antonio Russo, President of the Conference, (Palermo, I) WELCOME TO THE CONFERENCE
Clara Natoli, President of CINBO (Chieti, I) 11.00 Guest Lectures:
Chairmen: Pierosandro Tagliaferri (Catanzaro, I) , C. Natoli (Chieti, I)
Early tumor shrinkage and depth of response to anti-EGFR in colorectal cancer: helpful surrogates or meaningless endpoints?
Marc Peeters (Anversa, BG)
Perspectives from translational research in gastrointestinal cancers
Giampaolo Tortora (Padova, I) 12.00 Light Lunch
SESSION 1:
Innovative strategies for gastrointestinal cancer Chairmen: Corrado Ficorella (L’Aquila, I) Giuseppe Tonini (Roma, I)
15.00 New anti-angiogenic agents in colorectal cancer Daniele Santini (Roma, I)
15.20 Regorafenib in colorectal cancer:
just a salvage treatment?
Erika Martinelli (Napoli, I)
15.40 Monoclonal antibodies in advanced gastric cancer Carlo Garufi (Pescara, I)
16.00 Intensive chemotherapy for pancreatic cancer Nicola Silvestris (Bari, I)
16.20 New chemotherapeutic agents for pancreatic cancer Davide Melisi (Verona, I)
16.40 Liquid biopsy in gastrointestinal cancers Marta Castiglia (Palermo, I)
17.00 Discussion 17.15 Coffee break
17.30 Case reports and Discussion
Chairmen: C. Garufi (Pescara, I) , B. Vincenzi (Roma, I) - Case report 1 Gemma Bruera (L’Aquila, I) - Case report 2 Antonio Galvano (Palermo, I)
Saturday – May 21, 2016
8.30 Guest Lecture:
Chairman: Pierosandro Tagliaferri (Catanzaro, I) The angiogenesis in ovarian cancer:
bevacizumab and beyond Domenica Lorusso (Milano, I)
SESSION 2: Innovative strategies for ovarian cancer Pierosandro Tagliaferri (Catanzaro, I),
Silverio Tomao (Roma, I)
9.00 New chemotherapy to overcome platinum resistance Laura Cortesi (Modena, I)
9.20 Next generation techniques for biomarker identifi cation Ettore Capoluongo (Roma, I)
9.40 Preventive/predictive role of susceptibility gene mutations Bernardo Bonanni (Milano, I)
10.00 The clinical development of PARP inhibitors Enrico Ricevuto (L’Aquila, I)
10.20 Discussion
10.35 Case reports and Discussion
Livio Blasi (Palermo, I), Enrico Ricevuto (L’Aquila, I) - Case report 1 Lorena Incorvaia (Palermo, I) - Case report 2 Valentina Calò (Palermo, I) 11.05 Coffee break
11.20 Guest Lecture:
Chairman: Franco Silvestris
The experience of Phase I trials in NSCLC:
what do we have to expect for next years?
Christian Rolfo (Anversa, BG)
SESSION 3 Innovation in 2nd line treatment for NSCLC Chairmen: Clara Natoli (Chieti, I)
Antonio Russo (Palermo, I)
11.50 Multi-target agents and angiogenesis Roberto Bianco (Napoli, I)
12.10 EGFR inhibitors for overcoming resistance Giuseppe Bronte (Palermo, I)
12.30 The right place for ALK inhibitors Mario Roselli (Roma, I)
12.50 The new chance of immune checkpoint inhibitors Emilio Bria (Verona, I)
13.05 Discussion
13.20 Case reports and Discussion
Chairmen: M. Roselli (Roma, I), Anna Russo (Palermo, I) - Case report 1 Vito Barbieri (Catanzaro, I) - Case report 2 Sergio Rizzo (Palermo, I)
Program Faculty
Vito Barbieri Catanzaro [email protected] Roberto Bianco Napoli
[email protected] Livio Blasi
Palermo [email protected] Bernardo Bonanni Milano
[email protected] Emilio Bria
Roma[email protected] Giuseppe Bronte Palermo
[email protected] - giuseppe.
[email protected] Gemma Bruera L’Aquila
[email protected] Valentina Calò
Palermo
[email protected] Ettore Domenico Capoluongo Roma[email protected] Marta Castiglia
Palermo
[email protected] Laura Cortesi
Modena
[email protected] Corrado Ficorella L’Aquila
fi [email protected] Antonio Galvano Palermo
[email protected] Carlo Garufi
Pescara
carlo.garufi @ausl.pe.it Lorena Incorvaia Palermo
[email protected] Domenica Lorusso Milano
[email protected] Erika Martinelli Napoli
Davide Melisi Verona
[email protected] Clara Natoli
Romanatoli@unich Marc Peters Anversa
[email protected] Enrico Ricevuto L’Aquila
[email protected] Sergio Rizzo
Palermo
[email protected] Christian Rolfo
Anversa MAIL Mario Roselli
Roma[email protected] - [email protected] Anna Russo
Palermo
[email protected] Antonio Russo Palermo
[email protected] Daniele Santini Roma[email protected] Franco Silvestris Bari[email protected] Nicola Silvestris
Bari[email protected] Piersandro Tagliaferri
Catanzaro [email protected] Silverio Tomao
Roma[email protected] Giuseppe Tonini
Roma[email protected] Giampaolo Tortora Verona Padova
[email protected] Bruno Vincenzi
Roma[email protected] 10.00 Participant registration
10.30
11.00 Guest Lectures:
12.00 Light Lunch
15.00 15.20
15.40 16.00 16.20 16.40
17.00 Discussion 17.15 Coffee break 17.30
8.30 Guest Lecture:
9.00 9.20 9.40
10.00
10.20 Discussion 10.35
11.05 Coffee break 11.20 Guest Lecture:
11.50 12.10 12.30 12.50
13.05 Discussion 13.20
